Production (Stage)
Fractyl Health, Inc.
GUTS
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 60.00K | 93.00K | 97.00K | 119.00K | 148.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.00K | 93.00K | 97.00K | 119.00K | 148.00K |
| Cost of Revenue | 31.00K | 50.00K | 52.00K | 70.00K | 93.00K |
| Gross Profit | 29.00K | 43.00K | 45.00K | 49.00K | 55.00K |
| SG&A Expenses | 21.30M | 23.10M | 20.99M | 20.70M | 17.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.81M | 93.62M | 81.40M | 71.50M | 60.42M |
| Operating Income | -96.75M | -93.53M | -81.30M | -71.38M | -60.27M |
| Income Before Tax | -89.11M | -68.69M | -62.90M | -55.48M | -68.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -89.11 | -68.69 | -62.90 | -55.48 | -68.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -89.11M | -68.69M | -62.90M | -55.48M | -68.48M |
| EBIT | -96.75M | -93.53M | -81.30M | -71.38M | -60.27M |
| EBITDA | -95.83M | -92.85M | -80.81M | -71.01M | -60.01M |
| EPS Basic | -1.84 | -1.53 | -12.20 | -21.32 | -37.58 |
| Normalized Basic EPS | -1.10 | -1.01 | -6.10 | -10.22 | -13.57 |
| EPS Diluted | -1.84 | -1.53 | -12.20 | -21.32 | -37.58 |
| Normalized Diluted EPS | -1.10 | -1.01 | -6.10 | -10.22 | -13.57 |
| Average Basic Shares Outstanding | 193.18M | 174.06M | 127.71M | 81.83M | 36.01M |
| Average Diluted Shares Outstanding | 193.18M | 174.06M | 127.71M | 81.83M | 36.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |